-
1
-
-
0018931354
-
5-fluorouracil, doxorubicin and mitomycin (FAM) combination chemotherapy for advanced gastric cancer
-
Macdonald J, Schein P, Woolley P. 5-fluorouracil, doxorubicin and mitomycin (FAM) combination chemotherapy for advanced gastric cancer. Ann Intern Med 1980;93:533-6.
-
(1980)
Ann. Intern. Med.
, vol.93
, pp. 533-536
-
-
Macdonald, J.1
Schein, P.2
Woolley, P.3
-
2
-
-
84944367593
-
A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma: Fluorouracil versus fluorouracil and doxorubicin versus fluorouracil, doxorubicin and mitomycin
-
Cullinan S, Moertel C, Fleming T. A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma: fluorouracil versus fluorouracil and doxorubicin versus fluorouracil, doxorubicin and mitomycin. JAMA 1985;253:2061-7.
-
(1985)
JAMA
, vol.253
, pp. 2061-2067
-
-
Cullinan, S.1
Moertel, C.2
Fleming, T.3
-
3
-
-
0028959887
-
Randomized comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer
-
Pyrhonen S, Kuitunen T, Nyandoto P, Kouri M. Randomized comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. Br J Cancer 1995;71:587-91.
-
(1995)
Br. J. Cancer
, vol.71
, pp. 587-591
-
-
Pyrhonen, S.1
Kuitunen, T.2
Nyandoto, P.3
Kouri, M.4
-
4
-
-
0024454042
-
Phase II study with the combination of etoposide, doxorubicin and cisplatin in advanced measurable gastric cancer
-
Preusser P, Wilke H. Achterrath W. Phase II study with the combination of etoposide, doxorubicin and cisplatin in advanced measurable gastric cancer. J Clin Oncol 1989;7:1310-17.
-
(1989)
J. Clin. Oncol.
, vol.7
, pp. 1310-1317
-
-
Preusser, P.1
Wilke, H.2
Achterrath, W.3
-
5
-
-
0022902979
-
An EORTC gastrointestinal group evaluation of the combination of sequential methotrexate and 5-fluorouracil combined with adriamycin (FAMTX) in advanced measurable gastric cancer
-
Wils J, Bleiberg H, Dalesio O. An EORTC gastrointestinal group evaluation of the combination of sequential methotrexate and 5-fluorouracil combined with adriamycin (FAMTX) in advanced measurable gastric cancer. J Clin Oncol 1986;4:1799-803.
-
(1986)
J. Clin. Oncol.
, vol.4
, pp. 1799-1803
-
-
Wils, J.1
Bleiberg, H.2
Dalesio, O.3
-
6
-
-
0025762832
-
Sequential high-dose methotrexate and fluorouracil combined with doxorubicin - A step ahead in the treatment of advanced gastric cancer: A trial of the EORTC's Gastrointestinal Tract Cooperative Group
-
Wils J, Klein H, Wegener DJT. Sequential high-dose methotrexate and fluorouracil combined with doxorubicin - a step ahead in the treatment of advanced gastric cancer: a trial of the EORTC's Gastrointestinal Tract Cooperative Group. J Clin Oncol 1991;9:827-31.
-
(1991)
J. Clin. Oncol.
, vol.9
, pp. 827-831
-
-
Wils, J.1
Klein, H.2
Wegener, D.J.T.3
-
7
-
-
0026548710
-
FAMTX versus etoposide, doxorubicin and cisplatin: A random assignment trial in gastric cancer
-
Kelsen D, Atiq OT, Saltz L, Niedzwiecki D. FAMTX versus etoposide, doxorubicin and cisplatin: a random assignment trial in gastric cancer. J Clin Oncol 1992;10:541-8.
-
(1992)
J. Clin. Oncol.
, vol.10
, pp. 541-548
-
-
Kelsen, D.1
Atiq, O.T.2
Saltz, L.3
Niedzwiecki, D.4
-
8
-
-
0031022803
-
Randomized trial comparing epirubicin, cisplatin and fluorouracil versus fluorouracil, doxorubicin and methotrexate in advanced esophagogastric cancer
-
Webb A, Cunningham D, Scarffe JH. Randomized trial comparing epirubicin, cisplatin and fluorouracil versus fluorouracil, doxorubicin and methotrexate in advanced esophagogastric cancer. J Clin Oncol 1997;15:261-7.
-
(1997)
J. Clin. Oncol.
, vol.15
, pp. 261-267
-
-
Webb, A.1
Cunningham, D.2
Scarffe, J.H.3
-
9
-
-
0036671779
-
Brief review of advances in the treatment of gastric carcinoma in North America and Europe, 1995-2001
-
Hasham-Jiwa N, Kasakura Y, Ajani JA. Brief review of advances in the treatment of gastric carcinoma in North America and Europe, 1995-2001. Int J Clin Oncol 2002;7:219-24.
-
(2002)
Int. J. Clin. Oncol.
, vol.7
, pp. 219-224
-
-
Hasham-Jiwa, N.1
Kasakura, Y.2
Ajani, J.A.3
-
10
-
-
0028487470
-
Docetaxel (Taxotere) in advanced gastric cancer: Results of a phase II clinical trial
-
EORTC Early Clinical Trials Group
-
Sulkes A, Smith J, Sessa C. Docetaxel (Taxotere) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials Group. Br J Cancer 1994;70:380-3.
-
(1994)
Br. J. Cancer
, vol.70
, pp. 380-383
-
-
Sulkes, A.1
Smith, J.2
Sessa, C.3
-
11
-
-
0034154069
-
Docetaxel (Taxotere)-cisplatin: An effective drug combination in gastric carcinoma
-
Swiss Group for Clinical Cancer Research (SAAK), and the European Institute of Oncology
-
Roth AD, Maibach R, Martinelli G. Docetaxel (Taxotere)-cisplatin: an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAAK), and the European Institute of Oncology. Ann Oncol 2000;11:301-6.
-
(2000)
Ann. Oncol.
, vol.11
, pp. 301-306
-
-
Roth, A.D.1
Maibach, R.2
Martinelli, G.3
-
12
-
-
0346790006
-
Docetaxel, cisplatin, 5-fluorouracil compared to cisplatin and 5-fluorouracil for chemotherapy-naive patients with metastatic or locally recurrent, unresectable gastric carcinoma. Interim results of a randomized phase III trial (V325)
-
Ajani JA, Van Cutsem E, Moiseyenko V. Docetaxel, cisplatin, 5-fluorouracil compared to cisplatin and 5-fluorouracil for chemotherapy-naive patients with metastatic or locally recurrent, unresectable gastric carcinoma. Interim results of a randomized phase III trial (V325). Proc Am Soc Clin Oncol 2003;22:249.
-
(2003)
Proc. Am. Soc. Clin. Oncol.
, vol.22
, pp. 249
-
-
Ajani, J.A.1
Van Cutsem, E.2
Moiseyenko, V.3
-
13
-
-
0029550022
-
Phase II trial of taxol in patients with adenocarcinoma of the upper gastrointestinal tract, the Eastern Cooperative Oncology Group (ECOG) results
-
Einsig AI, Lipsitz S, Wiernik PH, Benson AB. Phase II trial of taxol in patients with adenocarcinoma of the upper gastrointestinal tract, the Eastern Cooperative Oncology Group (ECOG) results. Invest New Drugs 1995;13:223-7.
-
(1995)
Invest. New Drugs
, vol.13
, pp. 223-227
-
-
Einsig, A.I.1
Lipsitz, S.2
Wiernik, P.H.3
Benson, A.B.4
-
14
-
-
18544381911
-
Effective combination chemotherapy with paclitaxel and cisplatin with or without human granulocyte colony-stimulating factor and/or erythropoietin in patients with advanced gastric cancer
-
Kornek GV, Raderer M. Schull B, Fiebiger W. Effective combination chemotherapy with paclitaxel and cisplatin with or without human granulocyte colony-stimulating factor and/or erythropoietin in patients with advanced gastric cancer. Br J Cancer 2002;86:1858-63.
-
(2002)
Br. J. Cancer
, vol.86
, pp. 1858-1863
-
-
Kornek, G.V.1
Raderer, M.2
Schull, B.3
Fiebiger, W.4
-
15
-
-
0035987101
-
Phase II study of weekly paclitaxel plus 24-h continuous infusion 5-fluorouracil, folinic acid and 3 weekly cisplatin for the treatment of patients with advanced gastric cancer
-
Honecker F, Kollmannsberger C, Quietzsch D, Haag C. Phase II study of weekly paclitaxel plus 24-h continuous infusion 5-fluorouracil, folinic acid and 3 weekly cisplatin for the treatment of patients with advanced gastric cancer. Anticancer Drugs 2002;13:497-503.
-
(2002)
Anticancer Drugs
, vol.13
, pp. 497-503
-
-
Honecker, F.1
Kollmannsberger, C.2
Quietzsch, D.3
Haag, C.4
-
16
-
-
0001095834
-
Final results of a phase II trial of CPT-11 in patients with advanced gastric cancer
-
Kohne CH, Thuss-Patience P, Catane R. Final results of a phase II trial of CPT-11 in patients with advanced gastric cancer. Proc Am Soc Clin Oncol 1999;18:258.
-
(1999)
Proc. Am. Soc. Clin. Oncol.
, vol.18
, pp. 258
-
-
Kohne, C.H.1
Thuss-Patience, P.2
Catane, R.3
-
17
-
-
0036561832
-
Irinotecan/cisplatin in advanced treated gastric or gastroesophageal junction carcinoma
-
Ajani JA, Baker J, Pisters PW, Ho L. Irinotecan/cisplatin in advanced treated gastric or gastroesophageal junction carcinoma. Oncology 2002;16:8-16.
-
(2002)
Oncology
, vol.16
, pp. 8-16
-
-
Ajani, J.A.1
Baker, J.2
Pisters, P.W.3
Ho, L.4
-
18
-
-
0036468440
-
CPT-11 plus cisplatin in patients with advanced, untreated gastric or gastroesophageal junction carcinoma
-
Ajani JA, Baker J, Pisters PW, Ho L. CPT-11 plus cisplatin in patients with advanced, untreated gastric or gastroesophageal junction carcinoma. Cancer 2002;94:641-6.
-
(2002)
Cancer
, vol.94
, pp. 641-646
-
-
Ajani, J.A.1
Baker, J.2
Pisters, P.W.3
Ho, L.4
-
19
-
-
0242356584
-
Randomized phase II trial of docetaxel plus irinotecan versus docetaxel plus 5-fluorouracil, in patients with untreated advanced gastric adenocarcinoma
-
Hawkins R, Cunningham D, Soerbye H. Randomized phase II trial of docetaxel plus irinotecan versus docetaxel plus 5-fluorouracil, in patients with untreated advanced gastric adenocarcinoma. Proc Am Soc Clin Oncol 2003;22:257.
-
(2003)
Proc. Am. Soc. Clin. Oncol.
, vol.22
, pp. 257
-
-
Hawkins, R.1
Cunningham, D.2
Soerbye, H.3
-
20
-
-
0031879628
-
Uracil-Tagafur in gastric carcinoma: A comprehensive review
-
Takiuchi H, Ajani JA. Uracil-Tagafur in gastric carcinoma: a comprehensive review. J Clin Oncol 1998;16:2877-85.
-
(1998)
J. Clin. Oncol.
, vol.16
, pp. 2877-2885
-
-
Takiuchi, H.1
Ajani, J.A.2
-
21
-
-
8044231966
-
Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin. A phase II study of the Oncopaz Cooperative Group
-
Feliu J, Baron MG, Garcia-Giron C. Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin. A phase II study of the Oncopaz Cooperative Group. Cancer 1996;78:211-16.
-
(1996)
Cancer
, vol.78
, pp. 211-216
-
-
Feliu, J.1
Baron, M.G.2
Garcia-Giron, C.3
-
22
-
-
0032801832
-
Epirubicin, cisplatin and oral UFT with leucovorin (ECU): A phase I-II study in patients with advanced upper gastrointestinal tract cancer
-
Seymour M, Dent JT, Papamichael D. Epirubicin, cisplatin and oral UFT with leucovorin (ECU): a phase I-II study in patients with advanced upper gastrointestinal tract cancer Ann Oncol 1999;10:1329-33.
-
(1999)
Ann. Oncol.
, vol.10
, pp. 1329-1333
-
-
Seymour, M.1
Dent, J.T.2
Papamichael, D.3
-
23
-
-
0036926036
-
Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced gastric cancer
-
Kim TW, Kang YK, Ahn JH. Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced gastric cancer. Ann Oncol 2002;13:1893-8.
-
(2002)
Ann. Oncol.
, vol.13
, pp. 1893-1898
-
-
Kim, T.W.1
Kang, Y.K.2
Ahn, J.H.3
-
24
-
-
0036740439
-
A phase I and pharmacokinetic study of capecitabine in combination with epirubicin and cisplatin in patients with inoperable esophagogastric adenocarcinoma
-
Evans TR, Pentheroudakis G, Paul S, McInnes A. A phase I and pharmacokinetic study of capecitabine in combination with epirubicin and cisplatin in patients with inoperable esophagogastric adenocarcinoma. Ann Oncol 2002;13:1469-78.
-
(2002)
Ann. Oncol.
, vol.13
, pp. 1469-1478
-
-
Evans, T.R.1
Pentheroudakis, G.2
Paul, S.3
McInnes, A.4
-
25
-
-
0036893770
-
Phase II study of oxaliplatin, fluorouracil and folinic acid in locally advanced or metastatic gastric cancer patients
-
Louvet C, Andre T, Tigaud JM, Gamelin E. Phase II study of oxaliplatin, fluorouracil and folinic acid in locally advanced or metastatic gastric cancer patients. J Clin Oncol 2002;20:4543-8.
-
(2002)
J. Clin. Oncol.
, vol.20
, pp. 4543-4548
-
-
Louvet, C.1
Andre, T.2
Tigaud, J.M.3
Gamelin, E.4
-
26
-
-
0037352255
-
Phase II study of oxaliplatin, 5 fluorouracil and leucovorin in previously platinum-treated patients with advanced gastric cancer
-
Kim DY, Kim JH, Lee SH. Phase II study of oxaliplatin, 5 fluorouracil and leucovorin in previously platinum-treated patients with advanced gastric cancer. Ann Oncol 2003;14:383-7.
-
(2003)
Ann. Oncol.
, vol.14
, pp. 383-387
-
-
Kim, D.Y.1
Kim, J.H.2
Lee, S.H.3
-
27
-
-
12244249161
-
Impact of adjuvant chemotherapy in the long-term outcome of patients with resected gastric cancer
-
Grau JJ, Martin M, Fuster J, Pera M. Impact of adjuvant chemotherapy in the long-term outcome of patients with resected gastric cancer. J Surg Oncol 2003;82:234-40.
-
(2003)
J. Surg. Oncol.
, vol.82
, pp. 234-240
-
-
Grau, J.J.1
Martin, M.2
Fuster, J.3
Pera, M.4
-
28
-
-
0027248855
-
Adjuvant therapy after curative resection for gastric cancer: Meta-analysis of randomized trials
-
Hermans J, Bonenkamp JJ, Boon MC, Bunt AM. Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials. J Clin Oncol 1993;11:1441-7.
-
(1993)
J. Clin. Oncol.
, vol.11
, pp. 1441-1447
-
-
Hermans, J.1
Bonenkamp, J.J.2
Boon, M.C.3
Bunt, A.M.4
-
29
-
-
0033166516
-
Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients. Revisiting a meta-analysis of randomized trials
-
Earle CC, Maroun JA. Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients. Revisiting a meta-analysis of randomized trials. Eur J Cancer 1999;35:1059-64.
-
(1999)
Eur. J. Cancer
, vol.35
, pp. 1059-1064
-
-
Earle, C.C.1
Maroun, J.A.2
-
30
-
-
0033816806
-
Efficacy of adjuvant chemotherapy after curative resection for gastric cancer. A meta-analysis of published randomized trials. A study of the GISCAD Group
-
Mari E, Floriani I, Tinazzi A. Efficacy of adjuvant chemotherapy after curative resection for gastric cancer. A meta-analysis of published randomized trials. A study of the GISCAD Group. Ann Oncol 2000;11:837-43.
-
(2000)
Ann. Oncol.
, vol.11
, pp. 837-843
-
-
Mari, E.1
Floriani, I.2
Tinazzi, A.3
-
31
-
-
0035434280
-
Meta-analyses of randomized trials of adjuvant chemotherapy in gastric cancer
-
Gianni L, Panzini I, Tassinari D. Meta-analyses of randomized trials of adjuvant chemotherapy in gastric cancer. Ann Oncol 2001;12:1178-80.
-
(2001)
Ann. Oncol.
, vol.12
, pp. 1178-1180
-
-
Gianni, L.1
Panzini, I.2
Tassinari, D.3
-
32
-
-
0035818048
-
Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction
-
Macdonald JS, Smalley SR, Benedetti J. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001;345:725-30.
-
(2001)
N. Engl. J. Med.
, vol.345
, pp. 725-730
-
-
Macdonald, J.S.1
Smalley, S.R.2
Benedetti, J.3
-
33
-
-
3242893117
-
Postoperative adjuvant chemoradiation for gastric or gastroesophageal adenocarcinoma using epirubicin, cisplatin and infusional 5FU (ECF) before and after CI 5-FU and radiotherapy: A multicenter pilot study
-
Fuchs C, Fitzgerald T, Mamon H. Postoperative adjuvant chemoradiation for gastric or gastroesophageal adenocarcinoma using epirubicin, cisplatin and infusional 5FU (ECF) before and after CI 5-FU and radiotherapy: A multicenter pilot study. Proc Am Soc Clin Oncol 2003;22:257.
-
(2003)
Proc. Am. Soc. Clin. Oncol.
, vol.22
, pp. 257
-
-
Fuchs, C.1
Fitzgerald, T.2
Mamon, H.3
-
34
-
-
0038298071
-
Future strategies and adjuvant treatment of gastric cancer
-
Falcone A. Future strategies and adjuvant treatment of gastric cancer. Ann Oncol 2003;14:45-7.
-
(2003)
Ann. Oncol.
, vol.14
, pp. 45-47
-
-
Falcone, A.1
-
35
-
-
0030451795
-
Phase II trial of docetaxel (taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: The Eastern Cooperative Oncology Group results of protocol E 1293
-
Einzig AI, Neuberg D, Remick SC. Phase II trial of docetaxel (taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: the Eastern Cooperative Oncology Group results of protocol E 1293. Med Oncol 1996;1113:87-93.
-
(1996)
Med. Oncol.
, vol.1113
, pp. 87-93
-
-
Einzig, A.I.1
Neuberg, D.2
Remick, S.C.3
-
36
-
-
0034449134
-
Front-line treatment of advanced gastric cancer with docetaxel and granulocyte colony stimulating factor (G-CSF): A phase II trial
-
Mavroudis D, Kourousis C, Androulakis N. Front-line treatment of advanced gastric cancer with docetaxel and granulocyte colony stimulating factor (G-CSF): a phase II trial. Am J Clin Oncol 2000;23: 341-4.
-
(2000)
Am. J. Clin. Oncol.
, vol.23
, pp. 341-344
-
-
Mavroudis, D.1
Kourousis, C.2
Androulakis, N.3
-
37
-
-
0036654749
-
2 is active and well-tolerated in patients with metastatic or recurrent gastric cancer: A phase II trial
-
2 is active and well-tolerated in patients with metastatic or recurrent gastric cancer: a phase II trial. Jpn J Clin Oncol 2000;32:248-54.
-
(2000)
Jpn. J. Clin. Oncol.
, vol.32
, pp. 248-254
-
-
Bang, Y.J.1
Kang, W.K.2
Kang, Y.K.3
-
38
-
-
18144450345
-
Late phase II clinical study of docetaxel in patients with advanced/recurrent gastric cancer: A Japanese Cooperative Study Group Trial
-
Taguchi T, Sakata Y, Kanamaru R. Late phase II clinical study of docetaxel in patients with advanced/recurrent gastric cancer: a Japanese Cooperative Study Group Trial. Gan To Kagaku Ryoho 1998;25:1915-25.
-
(1998)
Gan To Kagaku Ryoho
, vol.25
, pp. 1915-1925
-
-
Taguchi, T.1
Sakata, Y.2
Kanamaru, R.3
-
39
-
-
0000149185
-
Phase II study of docetaxel as second line chemotherapy in metastatic gastric cancer
-
Vanhoefer U, Wilke H, Harstrick A. Phase II study of docetaxel as second line chemotherapy in metastatic gastric cancer. Proc Am Soc Clin Oncol 1999;18:1163.
-
(1999)
Proc. Am. Soc. Clin. Oncol.
, vol.18
, pp. 1163
-
-
Vanhoefer, U.1
Wilke, H.2
Harstrick, A.3
|